Skip to main content

Hypertensive encephalopathy

Current Treatment Options in Cardiovascular Medicine volume 6, pages 209–216 (2004)Cite this article

Opinion statement

The term hypertensive encephalopathy should be reserved for patients with diffuse cerebral effects of precipitous and sustained rises in blood pressure that reverse when blood pressure is lowered and are not due to infarction or hemorrhage. The definitive diagnosis of this syndrome depends on accurate exclusion of other causes that may be associated with elevated blood pressure and neurologic deficits. Treatment is aimed at preventing or limiting target organ (brain) damage. Therapy should be individualized but centered on reducing the mean arterial blood pressure within a period of minutes to 2 hours, by no more than 20% to 25% or to a diastolic blood pressure of 100 to 110 mm Hg (whichever is higher), using short-acting intravenous agents. Oral or sublingual agents should generally be avoided in hypertensive encephalopathy because they are more likely to cause precipitous falls in blood pressure.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References and Recommended Reading

  1. Arterial hypertension. Report of a WHO expert committee [no authors listed]. World Health Organ Tech Rep Ser 1978, 628:7–56.

  2. Vaughan CJ, Delanty N: Hypertensive emergencies. Lancet 2000, 356:411–417. Details current pathophysiologic concepts of hypertensive emergencies and provides clear guidelines for the evaluation and treatment of hypertensive encephalopathy based on available evidence and expert opinion.

    PubMed  Article  CAS  Google Scholar 

  3. Brust JC, Healton EB, Feinfeld DA, et al.: Hypertensive encephalopathy and the neurologic manifestations of malignant hypertension. Neurology 1982, 32:127–132.

    PubMed  Google Scholar 

  4. Hinchey J, Chaves C, Caplan LR: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334:494–500.

    Article  Google Scholar 

  5. Tang-Wai DF, Phan TG, Wijdicks EF: Hypertensive encephalopathy presenting with thunderclap headache. Headache 2001, 41:198–200.

    PubMed  Article  CAS  Google Scholar 

  6. Haubrich C, Mull M, Block F, et al.: Hypertensive encephalopathy with a focal cortical edema in MRI. J Neurol 2001, 248:900–902.

    PubMed  Article  CAS  Google Scholar 

  7. Morello F, Marino A, Cigolini M: Hypertensive brainstem encephalopathy: clinically silent massive edema of the pons. Neurol Sci 2001, 22:317–320.

    PubMed  Article  CAS  Google Scholar 

  8. Verrees M, Filho JA, Suarez JI, et al.: Primary hypertensioninduced cerebellar encephalopathy causing obstructive hydrocephalus. J Neurosurg 2003, 98:1307–1311.

    PubMed  Article  Google Scholar 

  9. Schwartz RB, Mulkern RV, Gudbjartsson H, et al.: Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. Am J Neuroradiol 1998, 19:859–862.

    PubMed  CAS  Google Scholar 

  10. Sheth RD, Riggs JE, Bodenstenier JB, et al.: Parietal occipital edema in hypertensive encephalopathy: a pathogenic mechanism. Eur Neurol 1996, 36:25–28.

    Article  Google Scholar 

  11. Paulson OB, Strandgaard S, Edvinsson L: Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990, 2:161–192.

    PubMed  CAS  Google Scholar 

  12. Phillips RA, Greenblatt J, Krakoff LR: Hypertensive emergencies: diagnosis and management. Prog Cardiovasc Dis 2002, 45:33–48.

    PubMed  Article  Google Scholar 

  13. Blumenfeld JD, Laragh JH: Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens 2001, 14:1154–1167. Provides detailed explanations of cerebral autoregulation and the scientific basis for blood pressure targets, as well as the potential hazards when these principles are not strictly maintained.

    PubMed  Article  CAS  Google Scholar 

  14. Duley L: Magnesium sulfate in eclampsia. Eclampsia Trial Collaborative Group. Lancet 1998, 352:67–68.

    PubMed  Article  CAS  Google Scholar 

  15. Suarez JI: Treatment of acute brain edema. Rev Neurol 2001, 32:275–281.

    PubMed  CAS  Google Scholar 

  16. Puddey IB, Beilin LJ, Rakic V: Alcohol, hypertension and the cardiovascular system: a critical appraisal. Addict Biol 1997, 2:159–170.

    Article  Google Scholar 

  17. Pincomb GA, Lovallo WR, McKey BS, et al.: Acute blood pressure elevations with caffeine in men with borderline systemic hypertension. Am J Cardiol 1996, 77:270–274.

    Article  Google Scholar 

  18. James JE: Is habitual caffeine use a preventable cardiovascular risk factor? Lancet 1997, 349:279–281.

    PubMed  Article  CAS  Google Scholar 

  19. Geleijnse JM, Witteman JC, Bak AA, et al.: Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ 1994, 309:436–440.

    PubMed  CAS  Google Scholar 

  20. Bonaa KH, Kjerve KS, Straume B, et al.: Effect of eicosapentaenoic acid and docosahexaenoic acid on blood pressure in hypertension. A population based intervention trial from the Tromso study. N Engl J Med 1990, 322:795–801.

    PubMed  CAS  Article  Google Scholar 

  21. Lipstein H, Lee CC, Crupi RS: A current concept of eclampsia. Am J Emerg Med 2003, 21:223–226. An up-to-date and evidence-based review of the pathophysiology, prevention, and treatment of eclampsia.

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Neurology, College of Physicians and Surgeons of Columbia University, Harlem Hospital, 506 Lenox Avenue, 10037, New York, NY, USA

    Olajide Williams MD & John C. M. Brust MD

Authors
  1. Olajide Williams MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John C. M. Brust MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Williams, O., Brust, J.C.M. Hypertensive encephalopathy. Curr Treat Options Cardiovasc Med 6, 209–216 (2004). https://doi.org/10.1007/s11936-996-0015-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-996-0015-9

Keywords

  • Mean Arterial Pressure
  • Nicardipine
  • Cerebral Perfusion Pressure
  • Labetalol
  • Main Side Effect